The Trio Laser Module for Hair Removal Treatment
Launched by ALMA LASERS · Oct 18, 2020
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Willing to undergo hair removal treatments at the Axilla and the Bikini line.
- • Between 18 and 70 years of age.
- • Reasonably good health, as defined by the Investigator.
- • Agrees to avoid tanning during their participation in this study.
- • Agrees to shave the treatment area prior to the treatment visit, according to the investigator's instructions.
- • Subjects with dark brown hair.
- • Eligible for treatment following a test spot without negative effects.
- • Provided written Informed Consent and photo consent.
- Exclusion Criteria:
- • History of laser hair removal in the treatment area.
- • Pregnant, lactating or planning to get pregnant within the study period.
- • Unwilling to use a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study, if of childbearing age.
- • History of photosensitivity or use of medication with photosensitizing properties.
- • Active infection in the treatment area.
- • History or evidence of any chronic or reoccurring skin disease or disorder affecting the treatment area.
- • History of keloid scarring or hypertrophic scar formation.
- • Tattoo in the treatment area.
- • Subject has been tanning within the past 30 days.
- • History of confounding cancerous or pre-cancerous skin lesions in the treatment area.
- • History of connective, metabolic or atrophic skin disease.
- • Subject has used prohibited therapies, oral prescription medication, or topical meds (steroids) on the treatment area within 30 days prior to enrollment.
- • History of autoimmune disorder
About Alma Lasers
Alma Lasers is a leading global innovator in the development of advanced medical and aesthetic laser technologies. With a commitment to enhancing patient outcomes and practitioner efficiency, the company specializes in a diverse range of laser and energy-based solutions for dermatology, surgery, and aesthetic treatments. Alma Lasers prioritizes research and clinical validation, actively sponsoring clinical trials to advance the efficacy and safety of its products. By fostering collaboration with healthcare professionals and leveraging cutting-edge technology, Alma Lasers continuously aims to set new standards in the medical aesthetics field, ensuring that practitioners have access to the most effective tools for delivering optimal patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Hollywood, Florida, United States
Patients applied
Trial Officials
Michael Gold, MD
Principal Investigator
Tennessee Clinical Research Center
Edwardo Weiss, MD
Principal Investigator
Skin Care Research, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials